Atopic dermatitis is one form of eczema which frequently develops in early infancy and is distinguished by a characteristic distribution, extreme pruritus, chronically relapsing course, and association with asthma and allergic rhinitisl. The distribution of the rash typically varies with age2, involving the cheeks and extensor surfaces of the arms and legs in infancy, the flexor surfaces in the young child, and flexor surfaces, hands and feet in the teenage patient and young adult. Unlike most dermatoses, atopic dermatitis has no primary skin lesion. The diagnostic criteria of Hanifin and Rajka have been internationally accepted as a standard for diagnosing atopic dermatitis3. The incidence of atopic dermatitis has been increasing over the past 40 years and is now estimated to affect between 10% and 12% of the paediatric population4.
Food sensitivity and the pathogenesis of atopic dermatitis
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FORMS OF ATOPIC DERMATITIS
As with asthma, there seem to be two forms of atopic dermatitis one in which the disease is triggered by allergens with potential IgE-dependency (extrinsic form) and one in which the disease appears to be IgE-independent (intrinsic form). The pathogenic role of antigen-specific IgE antibodies in atopic dermatitis is supported by studies delineating the classical immunopathogenic role of the IgEmediated cutaneous late-phase response and of the nonclassical role of IgE-bearing antigen-presenting cells (APCs), especially Langerhans cells and dendritic cells, in establishing the Th2 lymphocytic response. In the past, skin biopsy findings from patients with atopic dermatitis were felt to be incompatible with an IgE-mediated mechanism but rather were indicative of a classical type IV, cell-mediated, response. Histological examination of acute skin lesions of atopic dermatitis reveals spongiosis, epidermal hyperplasia, and ballooning of the keratinocytes secondary to intracellular oedema. Mast cell and basophil numbers are normal, and eosinophils are rare5. Chronic skin lesions typically lack the spongiosis but have moderate to marked hyperplasia of the epidermis, elongation of the rete ridges, and prominent hyperkeratosis. The number of mast cells and Langerhans cells are significantly increased in chronic lesions whereas eosinophils are reported to be infrequent. Capillary numbers are often increased and capillary walls appear thickened. Cutaneous nerves appear demyelinated and fibrotic at all levels of the dermis. Fibrosis of the upper dermis is a prominent finding in lichenified plaques.
IMMUNOPATHOGENESIS
In both acute and chronic lesions, a prominent lymphocytic infiltrate is seen. Immunohistochemical staining has demonstrated that the infiltrate is comprised predominantly of activated T cells bearing CD3, CD4 and CD45 RO antigens6'7. Essentially all T lymphocytes migrating into the skin bear the 'cutaneous lymphocyte antigen' (CLA), which functions as a skin-homing receptor for T cells8. Vascular endothelial cells in atopic dermatitis lesions express elevated levels of the receptor, VCAM-19, which plays an important role in targeting the homing of CLA+ T cells to sites of skin inflammation10. VCAM-1, which is induced by interleukin (IL)-4 and IL-1311, also plays an important role in the migration of eosinophils and mononuclear cells into sites of allergic inflammation. Increased numbers of Langerhans cells are found in chronic atopic dermatitis lesions and have been shown to have high-affinity [FcEI] and low-affinity [FcEIII IgE receptors and surface bound IgE molecules12. Mast cell numbers are also increased in chronic atopic dermatitis lesions. Typically mast cells bearing both tryptase and chymase (MCTC) are predominant in normal skin, but in eczematous skin increased numbers of mast cells bearing just tryptase (MCT-generally seen in the lung and gastrointestinal tract) are present in large numbers13. The development of MCT cells is dependent upon functional T cells, suggesting that infiltrating T cells are responsible for their presence in the eczematous lesions. Keratinocytes also show evidence of cytokine-induced activation. ICAM-1 is expressed on keratinocytes from atopic dermatitis lesions14, but in contrast to keratinocytes in contact dermatitis (classical delayed-type hypersensitivity (DTH)), HLA-DR is not expressed on the cell surface15.
Although histologic studies suggested that the eosiniphil (the cell type typically seen at the site of chronic allergic inflammation) was not present in atopic dermatitis lesions, immunocytochemical studies have demonstrated extensive deposition of eosinophil-derived extracellular major basic protein (MBP) in atopic dermatitis lesions but not in normal-appearing skin, and control studies on patients with contact dermatitis revealed no dermal deposition of MBP16. More recently increased numbers of EG2+-staining eosinophils have been demonstrated in chronic atopic dermatitis lesions, but not in acute lesions or normalappearing skin17. In addition, eosinophil cationic protein (ECP) has been shown to be elevated in the sera of patients with atopic dermatitis and to correlate with disease severity, providing further evidence for eosinophil involvement in atopic dermatitis18.
The patterns of cytokine expression found in lymphocytes infiltrating skin lesions of contact dermatitis and atopic dermatitis have been evaluated and compared utilizing in situ hybridization. In classic DTH reactions (e.g. tuberculin skin reaction), infiltrating T cells express predominantly the have been shown to be 100to 1000-fold more efficient at presenting allergen (dust mite) to T cells, primarily Th2 cells, and activating T cell proliferation24'25. Finally, it has been demonstrated that patients with IgE-mediated milkinduced skin symptoms possess allergen-specific, CLA+ T cells in their circulation, which are not present in patients with milk-induced gastrointestinal disease26. This suggests that atopic dermatitis patients with milk-induced eczema possess T cells which facilitate the localization of the inflammatory response to the skin. In summary, various recent immunological studies indicate that allergen-specific IgE antibodies may function in several ways to initiate and perpetuate allergic inflammation in the skin.
FOOD ALLERGY AND THE PATHOGENESIS OF ATOPIC DERMATITIS
Whether food allergy is pathogenic in atopic dermatitis has been disputed for nearly a century27. Several lines of evidence support a pathogenic role for food hypersensitivity in atopic dermatitis: (1) studies of food allergen avoidance infants; (2) food challenge studies provoke immunological changes that have been associated with the development of eczematous lesions; and (3) identification and elimination of food allergens leads to clinical improvement and return of abnormal immunologic parameters to normal. One study from the USA reported that approximately one-third of children seen in a university combined dermatology and allergy clinic had food hypersensitivity contributing to their skin symptoms28, and a second study from France demonstrated that the more severe the atopic dermatitis, the more likely that food allergy is pathogenic29. As discussed below, a single isolated ingestion of a food allergen does not provoke an eczematous lesion, but repeated ingestions do result in typical changes of atopic dermatitis.
Since Grulee and Sanford reported that exclusive breastfeeding reduced atopic dermatitis sevenfold compared to cow's milk in a large cohort of infants30, the effectiveness of breast-feeding and various measures to prevent food allergy and atopic disease has been debated. In a prospective study of 446 unselected preterm neonates, the protective effect of human breast milk or a preterm formula were compared3l.
Infants from atopic families receiving banked human breast milk had significantly less atopic dermatitis at 18 months than infants receiving formula; 16% versus 41%. In a prospective study of 1726 Danish infants, those exclusively breast-fed for more than one month had significantly less cow's milk allergy/intolerance than infants never breast-fed or breast-fed for less than one month; 1.7% versus 4.1%32.
In two other studies, infants from atopic families whose mothers excluded egg, milk and fish from their diets during lactation (prophylaxis group) were found to have significantly less atopic dermatitis and food allergy at 18 months compared to infants whose mothers' diets were indicate that atopic dermatitis can be prevented in some group had less atopic dermatitis, as shown in Figure 1 , but no difference in food allergy or respiratory allergy was seen35. In a prospective non-randomized study of 1265 unselected neonates, the effect of solid food introduction was evaluated over 10 years36'37. A significant linear relationship was found between the number of solid foods introduced into the diet by 4 months of age and subsequent atopic dermatitis, with a threefold increase in recurrent eczema at 10 years of age in infants receiving four or more solid foods compared to infants receiving no solid foods prior to 4 months of age. No such relationship was noted between asthma and the introduction of solid foods. A prospective non-randomized study comparing breast-fed infants who first received solid foods at 3 months or 6 months of age, revealed reduced atopic dermatitis and food allergy at 1 year of age in the group avoiding solids for the 6-month period38, but no significant difference in these parameters at 5 years39. Finally, a prospective, randomized allergy prevention trial compared the benefits of maternal and infant food allergen avoidance in the prevention of allergic disease in infants at high risk for atopic disease40A3.
Breast-feeding was encouraged in both prophylaxis and control groups. In the prophylaxis group, both the diets of lactating mothers and infants were restricted of egg, cow's milk and peanut. The control infants received cow's milk formula for supplementation. The period prevalences of food allergy, cow's milk sensitization and atopic dermatitis in the prophylaxis group were reduced significantly during the first 2 years compared to the control group, but were no longer significantly different beyond 2 years. The cumulative prevalence of food allergy remained lower in the prophylaxis group at 4 and 7-year follow-up, suggesting that the benefits of food allergy preventative measures are of limited duration, primarily because of the frequent remission of food allergy in early childhood43. Overall, it appears that food allergen avoidance diets for genetically predisposed infants have their greatest effect on the development of atopic dermatitis, but that this effect may be limited to those with milder disease who are likely to 'outgrow' it after the first few years. My co-workers and I have studied 470 children and adolescents (median age 4.1 years, range 6 months to 25 years) with atopic dermatitis for evidence of food hypersensitivity. Patients were highly atopic with 80% having elevated total serum IgE concentrations (median 3410 IU/mL), 91% having positive family histories for atopic disease, and 39% having both asthma and allergic rhinitis at the time of initial evaluation (only 23% have atopic dermatitis alone at the initiation of study). Doubleblind placebo-controlled food challenges (DBPCFC) provoked a variety of symptoms within minutes to 2 h in nearly 80% of the patients studied. Cutaneous reactions were confined to the skin alone in only 27% of positive responses. During the first evaluation, skin symptoms provoked by DBPCFC generally included a markedly pruritic, erythematous, morbilliform rash which developed in predilection sites for atopic dermatitis. Urticarial lesions were rarely seen. However, urticaria was seen often in follow-up challenges conducted 1 to 2 years later in patients who had adhered to an appropriate allergen elimination diet and had experienced clearing of their eczema, but who remained food sensitive. Although history had not suggested other food-induced complaints, gastrointestinal symptoms developed in 50% of patients (nausea, abdominal cramping, and vomiting and/or diarrhoea), upper respiratory symptoms, especially laryngeal oedema (sensation of itching and tightness in the throat, persistent throat clearing with dry hacking cough, and hoarseness) in 45%, and wheezing in about 15% of positive challenges.
Both immediate and late-phase effects of ingested food allergens were documented during DBPCFCI ,16,44 47. The pruritic, erythematous morbilliform rash, which is a hallmark of the immediate skin response, generally arose abruptly and persisted for 30-150min. Several laboratory findings implicated IgE-mediated cutaneous mast cell activation in the pathogenesis of these lesions: (1) a sharp rise in plasma histamine concentration in conjunction with positive DBPCFC (Figure 2 ); (2) no evidence of immediate activation of circulating basophils as evidenced by lack of change in circulating basophil number, total histamine content, or spontaneous histamine release in vitro in association with a positive food challenge; and (3) no significant change in the plasma complement activation products, C3a or C5a, in conjunction with positive food challenges. In macular rash approximately 4-8 h following primary skin reaction. Peripheral blood eosinophils were found to decrease approximately 6-8 h following a positive food challenge but by 14-18 h post-challenge had returned to pre-challenge levels with a shift to increased numbers of hypodense (activated) eosinophils, as confirmed more recently by others48. In addition, serum ECP levels have been reported to rise following a positive food challenge49. prostaglandins and platelet-activating factor have been reported as prominent in atopic dermatitis and support a pathogenic role for IgE-mediated late phase reaction. The continuous ingestion of food allergens by children with positive DBPCFC was found to be associated with high levels of 'spontaneous' basophil histamine release in vitro and the 'spontaneous' production of histamine-releasing factor (HRF) from mononuclear cells in vitro, and most likely in vivo45S50. The generation of HRF was associated with increased spontaneous basophil histamine release in vitro, increased basophil releasibility in vitro, and increased cutaneous hyperirritability (state of increased reactivity to a variety of minor non-specific stimuli, e.g. irritants, detergents, heat, cold, etc.). Increased numbers of 'activated' eosinophils (increased numbers of hypodense eosinophils, Figure 3 clinical scores (ingesting food allergens) were more releasable and 'activated' ('primed') than those from atopic dermatitis patients with low clinical scores (avoiding appropriate food allergens) (James JM, Kagey-Sobotka A, Sampson HA. J Allergy Clin Immunol 1993;91:1 155-see Ref 51) to C5a in vitro, Figure 4 ) were found in food-allergic children with atopic dermatitis ingesting food allergens51.
In order to better understand the role of the cutaneous mast cell in eczematous lesions, the response of cutaneous mast cells to contact with various allergens was assessed by introducing 'relevant' (food antigen to which the patient was skin test and oral challenge positive) and 'irrelevant' food allergens (food antigen to which patient was skin test positive and oral challenge negative) into skin blister chambers47. The chamber blister fluid was then monitored for changes in mediator and cell content. No differences in immediate and late-phase histamine or PGD2 concentrations were seen when 'relevant' or 'irrelevant' food allergens were placed in the chamber. Since food antigens have been shown to enter the circulation of virtually anyone ingesting food, it was postulated that the difference between sensitized patients with or without clinical reactivity appears to depend upon factors intervening between gastrointestinal antigen absorption and target organ, e.g. modification of the antigen upon absorption, clearing by reticuloendothelial cells or circulating antibodies, etc.
With the institution of appropriate allergen elimination diets, clinical symptoms improved and many immunological indices became normal. Activated eosinophil numbers in the peripheral blood returned to normal (Figure 3 ), as did basophil activation status (Figure 4 )51. Spontaneous generation of HRF decreased to background levels over [6] [7] [8] [9] months when the food allergens were identified and removed from the diet. In addition, spontaneous basophil histamine release returned to background levels, basophil releasibility became normal, and cutaneous hyperirritability diminished.
To better understand the target organ specificity of food-induced eczematous lesions, peripheral blood mononuclear cells (PBMCs) from seven patients with atopic 5 0 LCS 10 0 HCS 14 dermatitis and milk allergy, 10 with milk-induced gastroenteropathies, and eight normal controls were stimulated in vitro with casein and then evaluated for expression of homing receptors26. Only patients with atopic dermatitis and milk allergy demonstrated a significant increase in CLA+ T cells, indicating that the homingreceptor expression on antigen-specific T cells may play a role in determining tissues of involvement in allergic responses.
In a prospective follow-up study of 34 patients with atopic dermatitis depicted in Figure 5 , 17 children with food allergy (group 1) who were appropriately diagnosed and placed on an allergen elimination diet experienced a marked and significantly greater improvement in their eczematous rash at 1-2 year and 3-4 year follow-up than 12 similar patients who did not have food allergy (group 2) and 5 children who were food allergic but did not adhere to the Changes associated with the allergen elimination diet were not confined to the skin in food-allergic patients. Lactulose absorption studies (a measure of gastrointestinal permeability) were abnormal in food-allergic children with atopic dermatitis while ingesting food allergens, but subsequently became normal when the responsible food allergens were eliminated from the diet52. In addition, these children were frequently noted to develop improved appetites and experienced some 'catch-up' weight gain. This study indicated that patients with atopic dermatitis and food hypersensitivity had subclinical malabsorption which was reversed when food allergens were removed from the diet. Five foods were found to account for nearly 90% of the food-induced reactions seen: egg, milk, peanut, soy, and wheat. Egg allergy was the most prevalent, affecting nearly two-thirds of the children with food hypersensitivity. In our highly selected, tertiary referral population, 20% of the children were not allergic to any foods, but 29% were allergic to one food, 23% to two foods, 13% to three foods, 8% to four foods, and 7% to five or more food antigens. Clinical food hypersensitivity was shown to be highly specific. Although specific IgE antibodies were often present to many members of plant and animal families, patients generally reacted only to one or two members of that food family when ingested. For example, significant in vitro crossreactivity was seen among the legume family by prick skin tests, RAST and immunoblots, but little clinical crossreactivity was observed when food antigens were actually ingested53'54. Likewise studies with cereal grains showed significant IgE antibody cross-reactivity between grains and grass pollens but little clinical cross-reactivity55. Therefore, in order to provide the most nutritionally complete allergen-free diets, DBPCFC or controlled elimination diets should be recommended. 75 patients were rechallenged 1-2 years after completely eliminating the responsible food allergen from their diet. Approximately one-third of symptomatic food allergies had resolved by the time of the second DBPCFC46.
The likelihood of developing clinical tolerance was dependent upon the food to which the child was reactive; e.g. the development of tolerance to soy was common whereas development of tolerance to peanut was extremely rare. Results of prick skin tests are of little value in predicting loss of clinical reactivity since most remained virtually unchanged for years after the child could tolerate a specific food.
Other investigators utilizing similar food challenge regimens also have demonstrated the pathogenic link between food hypersensitivity and atopic dermatitis. In their studies of children primarily with suspected food hypersensitivity and respiratory allergy, May and Bock reported that 4 of 7 children with a history of eczematous reactions to foods developed rashes within 2 h of administration of a double-blind placebo-controlled oral food challenge56. Burks and co-workers have also employed the double-blind placebo-controlled oral food challenge to study 46 children with mild to severe atopic dermatitis presenting to a university dermatology and allergy clinic28. As seen in other controlled oral challenge studies, children experienced cutaneous, respiratory and gastrointestinal symptoms. One-third of the children reportedly developed symptoms during the blinded food challenges. Interestingly, no correlation was seen between the likelihood of having a positive food challenge and the severity of the skin In summary, IgE antibodies bind high-affinity FcEj receptors on mast cells, basophils, Langerhans cells and monocytes of atopic individuals as well as low affinity FcE11 receptors on antigen-presenting cells (macrophages, monocytes, Langerhans cells, dendritic cells), lymphocytes, eosinophils and platelets. When food allergens penetrate mucosal barriers and reach IgE antibodies bound to mast cells, mediators such as histamine, prostaglandins and leukotrienes are released. The activated mast cells also release cytokines (e.g. IL-4, IL-5, IL-6, TNF-x, PAF) that may promote further inflammation. During the initial 4-8 h of the reaction, primarily eosinophils invade the site of response. These infiltrating cells are activated and release mediators including PAF, eosinophil MBP, eosinophil cationic protein (ECP) and cytokines. In the subsequent 2448 h, lymphocytes and monocytes infiltrate the area and establish the more chronic inflammatory picture. Proper identification of responsible food allergens and their complete elimination from the diet can result in a reversal of immunopathogenic mechanisms and improvement in the patient's skin condition.
